The cells are handled in a controlled “ISO5” environment surrounded by an ISO7/resting or ISO8 controlled environment in operation.

Cellavita's facilities and Good Manufacturing Practices for Advanced Cell Therapy products follow the regulations of RDC 441/2011, RDC 11/2009 and part of RDC 55/2015, in addition to the specific requirements of RDC No. 214, of February 07th, 2018 related to the Cell Processing Center.

The quality parameters of the product and production follow the regulations of Anvisa and Brazilian Pharmacopoeia "Food Drug Administration" - FDA, International Cellular Therapy Society, "European Medicines Agency" - EMA.